| scholarly article | Q13442814 |
| P50 | author | Fernanda Majolo | Q57128265 |
| P2093 | author name string | Eliseu Paglioli | |
| Jaderson Costa da Costa | |||
| Vinicius Duval da Silva | |||
| Denise Cantarelli Machado | |||
| Alessandra Deise Sebben | |||
| André Palmini | |||
| Daniel Rodrigo Marinowic | |||
| Tiago Giuliani Lopes | |||
| P2860 | cites work | Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1. | Q27303723 |
| The phosphoinositide 3-kinase pathway | Q27860738 | ||
| Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 | ||
| Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
| Cerebral organoids model human brain development and microcephaly | Q28973619 | ||
| The genetics of ageing | Q29547430 | ||
| Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells | Q29615870 | ||
| Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome | Q29616636 | ||
| A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells | Q29619964 | ||
| PI3K/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia | Q30300538 | ||
| Stem cell derived basal forebrain cholinergic neurons from Alzheimer's disease patients are more susceptible to cell death | Q30566020 | ||
| Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice | Q30569745 | ||
| Epilepsy and malformations of cortical development: new developments | Q30895711 | ||
| Mutant astrocytes differentiated from Rett syndrome patients-specific iPSCs have adverse effects on wild-type neurons | Q33582775 | ||
| Identification and rescue of α-synuclein toxicity in Parkinson patient-derived neurons | Q33616462 | ||
| A cytoplasmic RNA vector derived from nontransmissible Sendai virus with efficient gene transfer and expression | Q33808044 | ||
| Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion | Q33878156 | ||
| iPSC-derived forebrain neurons from FXS individuals show defects in initial neurite outgrowth | Q33919340 | ||
| The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. | Q33928657 | ||
| GluD1 is a common altered player in neuronal differentiation from both MECP2-mutated and CDKL5-mutated iPS cells | Q34231583 | ||
| Focal cortical dysplasia - review | Q34356320 | ||
| Neuronopathic Gaucher's disease: induced pluripotent stem cells for disease modelling and testing chaperone activity of small compounds | Q34464236 | ||
| Modeling a genetic risk for schizophrenia in iPSCs and mice reveals neural stem cell deficits associated with adherens junctions and polarity | Q34540416 | ||
| Caenorhabditis elegans 2007: the premier model for the study of aging | Q34584504 | ||
| The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission | Q34683964 | ||
| SMRT compounds abrogate cellular phenotypes of ataxia telangiectasia in neural derivatives of patient-specific hiPSCs | Q34709237 | ||
| Human iPSC-derived motoneurons harbouring TARDBP or C9ORF72 ALS mutations are dysfunctional despite maintaining viability | Q35114316 | ||
| Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks | Q35132073 | ||
| Malformations of cortical development: clinical features and genetic causes | Q35188898 | ||
| A striatal-enriched intronic GPCR modulates huntingtin levels and toxicity | Q35214858 | ||
| MECP2e1 isoform mutation affects the form and function of neurons derived from Rett syndrome patient iPS cells | Q35235695 | ||
| Terminology and classification of the cortical dysplasias | Q35705741 | ||
| Probing disorders of the nervous system using reprogramming approaches | Q35761135 | ||
| Reprogramming patient-derived cells to study the epilepsies | Q35789597 | ||
| Erosion of dosage compensation impacts human iPSC disease modeling | Q36703082 | ||
| Focal dysplasia of the cerebral cortex in epilepsy | Q37078340 | ||
| Abnormal development of the human cerebral cortex: genetics, functional consequences and treatment options | Q37080467 | ||
| The adult human brain in preclinical drug development | Q37212752 | ||
| Inhibition of mitochondrial fragmentation diminishes Huntington's disease-associated neurodegeneration | Q37384081 | ||
| LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson's disease patients: reversal by gene correction | Q37424610 | ||
| Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. | Q37444336 | ||
| The human brain in a dish: the promise of iPSC-derived neurons | Q37887868 | ||
| PI3-kinase/Akt/mTOR signaling: impaired on/off switches in aging, cognitive decline and Alzheimer's disease | Q38087439 | ||
| Current methods and challenges in the comprehensive characterization of human pluripotent stem cells. | Q38287660 | ||
| Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons | Q39007648 | ||
| Modeling Dravet syndrome using induced pluripotent stem cells (iPSCs) and directly converted neurons | Q39138608 | ||
| Neural differentiation of patient specific iPS cells as a novel approach to study the pathophysiology of multiple sclerosis. | Q39408674 | ||
| Evidence of fibroblast heterogeneity and the role of fibroblast subpopulations in fibrosis | Q40625104 | ||
| The expression of pluripotency genes and neuronal markers after neurodifferentiation in fibroblasts co-cultured with human umbilical cord blood mononuclear cells. | Q42797850 | ||
| Modeling familial Alzheimer's disease with induced pluripotent stem cells | Q42817521 | ||
| Generation of induced pluripotent stem cells from skin fibroblasts of a patient with olivopontocerebellar atrophy | Q42818697 | ||
| Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression | Q42823656 | ||
| Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients. | Q46970598 | ||
| Abnormal maturation and differentiation of neocortical neurons in epileptogenic cortical malformation: unique distribution of layer-specific marker cells of focal cortical dysplasia and hemimegalencephaly | Q48452255 | ||
| Induction of pluripotent stem cells from fibroblast cultures | Q48770547 | ||
| Altered oxygen metabolism associated to neurogenesis of induced pluripotent stem cells derived from a schizophrenic patient | Q48860052 | ||
| Pathologic characteristics of the cortical dysplasias | Q77381444 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 2049-2056 | |
| P577 | publication date | 2017-03-01 | |
| P1433 | published in | Molecular Medicine Reports | Q26842180 |
| P1476 | title | Induced pluripotent stem cells from patients with focal cortical dysplasia and refractory epilepsy | |
| P478 | volume | 15 |
| Q93196052 | From molecules to medicines: the dawn of targeted therapies for genetic epilepsies |
| Q89261614 | MTOR pathway in focal cortical dysplasia type 2: What do we know? |
| Q93080568 | Oncogenic Notch Triggers Neoplastic Tumorigenesis in a Transition-Zone-like Tissue Microenvironment |
| Q90613212 | Protective Effects of Melatonin on the Skin: Future Perspectives |
Search more.